Tech & Science
AI in pharma
Nvidia and Eli Lilly Commit Up to $1 Billion to a Co-Innovation Lab for AI-Native Drug Discovery
The five-year South San Francisco lab co-locates Lilly biology, chemistry and clinical scientists with Nvidia AI engineers, anchored on BioNeMo, the Vera Rubin GPU architecture and Lilly's pharma-industry-leading internal supercomputer.